Sandra Algaze in Los Angeles, California

Home California Los Angeles

Sandra Algaze has Medical Oncology as her primary medical specialty. Their primary office is: 1520 San Pablo St 1st Floor N in Los Angeles, California. There are 6 additional office locations for Sandra Algaze that can be viewed towards the end of their profile.

They're a part of the: Usc Care Medical Group Inc medical group which has around 1,122 members. You can call their office at 800-872-2273 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, her university is not listed and graduated in 2015 (around 9 years of experience). They are listed as doing telehealth appointments.

Sandra Danielle Algaze Office Phone and Directions

Sandra Algaze
Usc Care Medical Group Inc
1520 San Pablo St 1st Floor N
Los Angeles, California 90033
800-872-2273

Patient Ratings
Please rate your experience with Sandra Algaze below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 800-872-2273

Enter a starting address:

Healthcare Info for Sandra Algaze

Additional Medical Specialties Include:
INTERNAL MEDICINE

Medical School: Sorry, her university is not listed
Graduation Year: 2015
The Primary Medical Specialty for Sandra Algaze is listed as: Medical Oncology
Approximate Years of Experience: 9
PAC (PECOS ID)#: 5597010058
NPI #: 1861886707
NPI Created On: 03/27/2015
NPI Last Updated Listed as: 12/08/2021
Primary Taxonomy Code: 207RX0202X
License Number:
A156237
Listed Gender: Female

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 818679355

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: CYRAMZA

Open Associated Drug #1: 0002-7669-01

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: VERZENIO

Associated Drug #2: 0002-6216-54

Drug or Biological #3:: Drug

Product Category #3: Oncology

Name of Drug: RETEVMO

Name Of Drug #3: 0002-2980-60

Payments Total: $29

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 818679357

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: VERZENIO

Open Associated Drug #1: 0002-6216-54

Payments Total: $29

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 818747253

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: VERZENIO

Open Associated Drug #1: 0002-6216-54

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: RETEVMO

Associated Drug #2: 0002-2980-60

Payments Total: $20

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 789064227

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: Stivarga

Open Associated Drug #1: 50419-171-03

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: Vitrakvi

Associated Drug #2: 71777-390-01